Based on the latest figures, Illumina reports a gross margin of 67.9%, an operating margin of 21.2%, an EBITDA margin of 31.6%, and a net margin of 19.7%. Net margin had the largest improvement, gaining by 3.3 percentage points, while the other available margins also increased.
Over the last 3 years, Illumina recorded average margins of 64.93% gross, -3.35% operating, 5.31% EBITDA, and -7.23% net. The current gross, operating, EBITDA, and net margins are all above their three-year averages.
Year over year, gross, operating, EBITDA, and net margins all increased, with net margin showing the largest gain at 3.3 percentage points.
Illumina's gross margin averaged 64.93% over the last 3 years. Compared with its three-year average, Illumina's current gross margin is 67.9% and is 3 percentage points above its three-year average. Over the last 3 years, Illumina's gross margin peaked at 67.9% in Sep 2026 and reached a low of 60.9% in Dec 2023.
Illumina recorded an average operating margin of -3.35% across the last 3 years. At present, the current operating margin for Illumina is 21.2%, 24.6 percentage points above its three-year average. The operating margin for Illumina moved between -60.2% in Jun 2024 and 30.2% in Jun 2025.
Across the last 3 years, Illumina's EBITDA margin came to 5.31%. The current EBITDA margin stands at 31.6%, 26.3 percentage points above its three-year average. EBITDA margin was highest at 41.6% in Jun 2025 and lowest at -57.1% in Jun 2024.
Illumina recorded an average net margin of -7.23% across the last 3 years. Illumina currently reports a net margin of 19.7%, 26.9 percentage points above its three-year average. Net margin was highest at 29.4% in Jun 2025 and lowest at -68.7% in Jun 2024.
Illumina's gross margin of 67.9% is above the industry and its peers average but below the Healthcare sector average. But compared to its Healthcare sector average of 68.3%, Illumina's gross margin is only 0.6% lower.
As of Sep 27, 2026, ILMN has a gross margin of 67.9%.
As of Sep 27, 2026, ILMN has an operating margin of 21.2%.
As of Sep 27, 2026, ILMN has an EBITDA margin of 31.6%.
As of Sep 27, 2026, ILMN has a net margin of 19.7%.
Across the last 3 years, ILMN averaged 64.9% gross, -3.4% operating, 5.3% EBITDA, and -7.2% net.
Looking back across 5 years, ILMN reached 69.7% gross in Jan 2022, 30.2% operating in Jun 2025, 41.6% EBITDA in Jun 2025, and 29.4% net in Jun 2025.
Looking back across 5 years, ILMN reached its lowest margins at 60.9% gross in Dec 2023, -99.6% operating in Apr 2023, -92.3% EBITDA in Apr 2023, and -100.9% net in Apr 2023.